Keyphrases
Plasminogen Activator inhibitor-1 (PAI-1)
100%
Pooled Analysis
100%
Breast Cancer Patients
100%
Urokinase-type Plasminogen Activator
100%
Prognostic Impact
100%
Prognostic Factors
25%
Nodal Status
25%
Possible Sources
12%
Ranking Data
12%
Breast Cancer
12%
Survival Analysis
12%
High-risk Population
12%
Metastasis-free Survival
12%
Low-risk Group
12%
Relapse-free Survival
12%
Medicine and Dentistry
Pooled Analysis
100%
Breast Cancer
100%
Urokinase
100%
Plasminogen Activator Inhibitor-1
100%
Base
12%
Survival Analysis
12%
Prognostic Factor
12%
High Risk Population
12%
Recurrence Free Survival
12%
Low Risk Population
12%
Prognostic Factor for Breast Cancer
12%
Metastasis Free Survival
12%
Immunology and Microbiology
High Risk Population
100%
Recurrence Free Survival
100%
Low Risk Population
100%
Metastasis Free Survival
100%
Agricultural and Biological Sciences
Plasminogen Activator Inhibitor-1
100%
Plasminogen Activator
100%
Malignant Neoplasm
100%
Endpoints
12%
Risk Groups
12%
Biochemistry, Genetics and Molecular Biology
Urokinase
100%
Plasminogen Activator Inhibitor-1
100%
High Risk Population
12%
Low Risk Population
12%
Recurrence Free Survival
12%
Metastasis Free Survival
12%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Urokinase
100%
Recurrence Free Survival
12%
Metastasis Free Survival
12%
Base
12%